Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052-7.

2.

Germline mutations in PTEN are present in Bannayan-Zonana syndrome.

Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C.

Nat Genet. 1997 Aug;16(4):333-4. No abstract available.

PMID:
9241266
3.

PTEN and myotubularin: novel phosphoinositide phosphatases.

Maehama T, Taylor GS, Dixon JE.

Annu Rev Biochem. 2001;70:247-79. Review.

PMID:
11395408
5.

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R.

Science. 1997 Mar 28;275(5308):1943-7.

6.

A highly conserved processed PTEN pseudogene is located on chromosome band 9p21.

Dahia PL, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, von Deimling A, Haluska FG, Haber DA, Eng C.

Oncogene. 1998 May 7;16(18):2403-6.

7.

The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase.

Charles CH, Sun H, Lau LF, Tonks NK.

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5292-6.

8.
9.

ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.

Tárrega C, Ríos P, Cejudo-Marín R, Blanco-Aparicio C, van den Berk L, Schepens J, Hendriks W, Tabernero L, Pulido R.

J Biol Chem. 2005 Nov 11;280(45):37885-94. Epub 2005 Sep 7.

10.

Phosphatases and tumorigenesis.

Parsons R.

Curr Opin Oncol. 1998 Jan;10(1):88-91. Review.

PMID:
9466490
11.

The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B.

Moeslein FM, Myers MP, Landreth GE.

J Biol Chem. 1999 Sep 17;274(38):26697-704.

12.

Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.

Slack DN, Seternes OM, Gabrielsen M, Keyse SM.

J Biol Chem. 2001 May 11;276(19):16491-500. Epub 2001 Jan 30.

13.

A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.

Agostinis P, Donella-Deana A, Van Hoof C, Cesaro L, Brunati AM, Ruzzene M, Merlevede W, Pinna LA, Goris J.

Eur J Biochem. 1996 Mar 1;236(2):548-57.

14.

A general peptide substrate for protein tyrosine phosphatases.

Daum G, Solca F, Diltz CD, Zhao Z, Cool DE, Fischer EH.

Anal Biochem. 1993 May 15;211(1):50-4.

PMID:
8323038
15.
16.
17.
18.

PTEN: sometimes taking it off can be better than putting it on.

Myers MP, Tonks NK.

Am J Hum Genet. 1997 Dec;61(6):1234-8. No abstract available.

19.

Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.

Palka HL, Park M, Tonks NK.

J Biol Chem. 2003 Feb 21;278(8):5728-35. Epub 2002 Dec 9.

Supplemental Content

Support Center